Patients with interstitial lung diseases (ILD) have impaired health-related quality of life (HRQL). Little is known about the applicability disease-specific King's Brief Interstitial Lung Disease questionnaire (K-BILD) and generic EQ-5D-5L in a German setting. We assessed HRQL (EQ-5D experience based value set (EBVS) Visual Analog Scale (VAS)) 229 patients different ILD subtypes longitudinal observational study (HILDA). Additionally, we correlation measures function comorbidities. In linear...

Evidence on the economic impact of chronic obstructive pulmonary disease (COPD) for third-party payers and society based large real world datasets are still scarce. Therefore, aim this study was to estimate COPD severity its comorbidities, stratified by GOLD grade, direct indirect costs an unselected population enrolled in structured German Disease Management Program (DMP) COPD.All individuals DMP were included analysis. Patients only excluded if they not insured or complete year before last...

Despite the availability of effective pharmaceutical treatment options, many patients with asthma do not manage to control their illness. This randomized trial a waiting-list group examined whether 3-week course inpatient pulmonary rehabilitation (PR) improves (primary endpoint) and other secondary endpoints (e.g., quality life, cardinal symptoms, mental stress). The subsequent observational segment study investigated long-term outcome after PR.

Asthma patients experience impairments in health-related quality of life (HRQL). Interventions are available to improve HRQL. EQ-5D-5L is a common generic tool used evaluate health interventions. However, there debate over whether the use this measure adequate asthma patients.We data from 371 participating pulmonary rehabilitation (PR) program EPRA randomized controlled trial. We four time points: T0 randomization, T1 start PR, T2 end T3 3 months follow-up. calculated floor and ceiling...

Risk attitudes influence decisions made under uncertainty. This paper investigates the association of risk with utilization preventive and general healthcare services, work absence resulting costs to explore their contribution heterogeneity in utilization.Data 1823 individuals (56.5 ± 9.5 years), participating German KORA FF4 population-based cohort study (2013/2014) were analyzed. Individuals' health attitude measured as willingness take (WTTR) on 11-point scales. Utilization medical...

Objectives: Patients with chronic obstructive pulmonary disease (COPD) show impairments in health-related quality of life (HRQL). We aimed to find a disease-specific questionnaire for routine application large cohorts and assess its additional explanatory power generic HRQL tool (EQ-5D-5L).Methods: 1,350 participants the management program COPD received EQ-5D-5L combined one three tools: Assessment Test (CAT), Clinical Questionnaire (CCQ) or St. George’s Respiratory Disease (SGRQ) (450...

Abstract Background Health-related quality of life (HRQL) in interstitial lung disease (ILD) patients is impaired. We aimed to identify baseline predictors for HRQL decline within a 12-month observation period. Methods analyzed 194 ILD from two German ILD-centers the observational HILDA study. employed disease-specific King’s Brief Interstitial Lung Disease questionnaire (K-BILD) with subdomains ‘psychological impact’, ‘chest symptoms’ and ‘breathlessness activities’, generic EQ-5D Visual...

<p class="abstract">Due to the novel nature of oral nicotine pouches, limited studies have been conducted on usage these products in real-world settings. Consumption patterns and use behaviour current pouch users need be investigated monitor support assessment reduced risk products. Here we report findings an online survey completed by 550 participants across Sweden, Denmark, Germany Switzerland who were users. The key areas research history, mouth hold duration, strength, average...

<b>Objectives:</b> Childhood Interstitial lung disease (chILD) is an umbrella term for more than 200 rare entities which there no evidence on optimal medications and clinical outcomes. We hypothesised that would be wide variations across Europe. <b>Methods:</b> The chILD-EU registry was initiated in 2012 currently includes children with ILD from 13 countries, analysis funded by COST Action CA16125 ENTeR-chILD. three most frequent prescribed at study baseline or within the next 3 months were...

<b>Background</b> Interstitial lung disease (ILD) is an umbrella term for more than 200 rare entities, with a high mortality in childhood and scarce information about healthcare management. <b>Objectives</b> This study seeks to fill the knowledge gap utilization of ILD patients. <b>Methods</b> For analysis we used data from observational chILD-EU (Children9s Lung Disease Europe) providing incident prevalent cases 4 countries substantial amount medical information. In baseline questionnaire...

Hintergrund Trotz guter medikamentöser Therapieoptionen erreichen auch in Deutschland fast 50% der Asthmatiker keine Asthmakontrolle (AC). Daher werden häufig pneumologische Rehabilitations(PR)-Programme eingeschlossen, wenngleich die Evidenz im Vergleich zur PR bei COPD geringer ist.

<b>Background:</b> There are sparse data about the long-term effects of PR on patients with asthma. <b>Method:</b> The EPRA-study (Effectiveness Pulmonary Rehabilitation for Patients Asthma) combined a randomized controlled waiting list trial (RCT) longitudinal follow-up design (3/6/9/12 months after rehab in all patients) to examine uncontrolled RCT compared AC (asthma control test, ACT) and QoL quality life questionnaire, AQLQ) [Intervention Group, IG] usual care [Control CG] showed...

Abstract Background: Health-related quality of life (HRQL) in interstitial lung disease (ILD) patients is impaired. We aimed to identify baseline predictors for HRQL decline within a 12-month observation period. Methods: analyzed 194 ILD from two German ILD-centers the observational HILDA study. employed disease-specific King’s Brief Interstitial Lung Disease questionnaire (K-BILD) with subdomains ‘psychological impact’, ‘chest symptoms’ and ‘breathlessness activities’, generic EQ-5D Visual...

<b>Background:</b> Patients with interstitial lung diseases (ILD) are a heterogeneous group of individuals high burden disease. Little is known about health care service provision and utilisation for ILD patients in Germany. <b>Aims objectives:</b> Assessment to what extent the German used by Patients. <b>Methods:</b> Data were obtained retrospective survey tertiary centre ILDs. Questionnaires on utilization services used. Considered was in- outpatient treatment general practioners...

<b>Background:</b> There is sparse evidence on the economic burden associated with Interstitial Lung Diseases (ILDs) and interaction between healthcare domains, especially level of distinct ILD-subtypes. To close this knowledge gap we performed a longitudinal analysis costs care for individuals different ILDs. <b>Methods:</b> We identified 37,489 patients newly diagnosed ILD—mostly IPF-related syndrome, sarcoidosis, fibrosing ILDs—between 2010 2012 based ICD-10 codes from German statutory...

EQ-5D-5L is a well-established generic quality of life (QoL) assessment tool, also used for calculating adjusted years. Its suitability in context pulmonary rehabilitation (PR) bronchial asthma has not been fully assessed yet.

There is sparse evidence on the economic burden associated with Interstitial Lung Diseases (ILDs) and interaction between healthcare domains, especially level of distinct ILD-subtypes. To close this knowledge gap we performed a longitudinal analysis costs care for individuals different ILDs.

Interstitial lung diseases (ILDs) are associated with a high burden of disease, but it remains unclear if there entity-specific differences in quality life (QoL). Our aim was to assess QoL and compare assessment by the generic EQ-5D-5L disease specific King's Brief Lung Disease questionnaire (K-BILD) across different ILD entities.

<b>Background:</b> The disease-specific Asthma Quality of Life Questionnaire (AQLQ) is well established. However, the generic EQ-5D-5L- tool for calculating Adjusted Years- in context pulmonary rehabilitation (PR) bronchial asthma has not been fully assessed yet. <b>Methods:</b> We calculated mean EQ-5D (Visual analog scale (VAS), experience based values (EBVS)) and AQLQ at baseline (T0), end (T2) 3 months after (T3) PR 173 patients with uncontrolled (Asthma Control Test&lt;20) from ongoing...

Hintergrund Depressionen und Ängste sind verbreite komorbide Erkrankungen bei Patienten mit unkontrolliertem Asthma. Bei COPD konnte in internationalen Studien (Coventry et al., 2007) gezeigt werden, dass eine Pneumologische Rehabilitation (PR) verringern kann. Für Asthma steht ein derartiger Nachweis noch aus.